Trial Profile
An Open-Label, Non-Randomized Phase I Study of the Protein Kinase C Inhibitor Flavopiridol Administered in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Paclitaxel (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- 11 Sep 2005 New trial record.